Bonstein Sara's Insider Trades & SAST Disclosures
Bonstein Sara's most recent trade in Insmed Inc was a trade of 31,610 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Bonstein Sara.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 31,610 | 31,610 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 6,508 | 114,867 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 67.81 per share. | 13 May 2025 | 8,870 | 109,993 (0%) | 0% | 67.8 | 601,475 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 65.61 per share. | 13 May 2025 | 1,634 | 108,359 (0%) | 0% | 65.6 | 107,207 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.28 per share. | 18 Feb 2025 | 17,622 | 119,563 (0%) | 0% | 80.3 | 1,414,694 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 81.00 per share. | 18 Feb 2025 | 700 | 118,863 (0%) | 0% | 81 | 56,700 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 11 Feb 2025 | 13,302 | 142,204 (0%) | 0% | 80 | 1,064,160 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 11 Feb 2025 | 5,019 | 137,185 (0%) | 0% | 80 | 401,520 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 65,033 | 183,896 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 80.90 per share. | 05 Feb 2025 | 28,390 | 155,506 (0%) | 0% | 80.9 | 2,296,751 | Common Stock |
| Xilio Therapeutics Inc | Sara M. Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| scPharmaceuticals Inc | Sara M. Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 19,750 | 19,750 | - | - | Stock Option (Right to Buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 28 May 2024 | 220,564 | 117,481 (0%) | 0% | 50 | 11,028,200 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.88 per share. | 28 May 2024 | 76,731 | 197,666 (0%) | 0% | 28.9 | 2,215,991 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 76,731 | 11,455 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.46 per share. | 28 May 2024 | 39,446 | 299,594 (0%) | 0% | 26.5 | 1,043,741 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 39,446 | 25,740 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. | 28 May 2024 | 32,156 | 358,769 (0%) | 0% | 17.1 | 548,903 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 32,156 | 59,350 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.70 per share. | 28 May 2024 | 27,074 | 228,194 (0%) | 0% | 24.7 | 668,728 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 27,074 | 4,362 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.03 per share. | 28 May 2024 | 25,046 | 256,694 (0%) | 0% | 34.0 | 852,315 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 25,046 | 17,100 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 28 May 2024 | 20,724 | 338,045 (0%) | 0% | 50.0 | 1,036,407 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.43 per share. | 28 May 2024 | 20,111 | 323,159 (0%) | 0% | 26.4 | 531,534 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 20,111 | 39,275 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.70 per share. | 28 May 2024 | 3,454 | 201,120 (0%) | 0% | 24.7 | 85,314 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.88 per share. | 28 May 2024 | 3,454 | 120,935 (0%) | 0% | 28.9 | 99,752 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.46 per share. | 28 May 2024 | 3,454 | 260,148 (0%) | 0% | 26.5 | 91,393 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.03 per share. | 28 May 2024 | 3,454 | 231,648 (0%) | 0% | 34.0 | 117,540 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 88,186 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.07 per share. | 28 May 2024 | 3,454 | 326,613 (0%) | 0% | 17.1 | 58,960 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.43 per share. | 28 May 2024 | 3,454 | 303,048 (0%) | 0% | 26.4 | 91,289 | Common Stock |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 91,506 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 59,386 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 65,186 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 42,146 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,454 | 31,436 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 71,160 | 71,160 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 14,518 | 128,569 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara M. Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.32 per share. | 13 May 2024 | 11,088 | 117,481 (0%) | 0% | 25.3 | 280,748 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 29.18 per share. | 09 Jan 2024 | 4,497 | 114,051 (0%) | 0% | 29.2 | 131,222 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 63,560 | 63,560 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 12,873 | 118,548 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Bonstein Sara | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 22 Dec 2023 | 13,199 | 105,241 (0%) | 0% | 30 | 395,970 | Common Stock |
| Xilio Therapeutics Inc | Sara Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| scPharmaceuticals Inc | Sara Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 17,300 | 17,300 | - | - | Stock Option (Right to Buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.30 per share. | 15 May 2023 | 2,210 | 119,229 (0%) | 0% | 19.3 | 42,653 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.47 per share. | 15 May 2023 | 1,610 | 117,619 (0%) | 0% | 18.5 | 29,737 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 158,410 | 158,410 | - | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 34,300 | 100,331 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 21,108 | 121,439 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.12 per share. | 10 Jan 2023 | 2,857 | 66,031 (0%) | 0% | 18.1 | 51,769 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 37,760 | 37,760 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 8,232 | 63,823 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 5,065 | 68,888 (0%) | 0% | - | Common Stock | |
| Xilio Therapeutics Inc | Sara Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| scPharmaceuticals Inc | Sara Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 16,300 | 16,300 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.51 per share. | 16 May 2022 | 1,433 | 54,683 (0%) | 0% | 18.5 | 26,525 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 94,960 | 94,960 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 20,137 | 56,116 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.11 per share. | 11 Jan 2022 | 1,154 | 35,979 (0%) | 0% | 25.1 | 28,977 | Common Stock |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 62,840 | 62,840 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 13,006 | 37,133 (0%) | 0% | - | Common Stock | |
| scPharmaceuticals Inc | Sara Bonstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 16,300 | 16,300 | - | - | Stock Option (Right to Buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 68,640 | 68,640 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 14,172 | 23,355 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 45,600 | 45,600 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 9,183 | 9,183 (0%) | 0% | - | Common Stock | |
| scPharmaceuticals Inc | Sara Bonstein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2020 | 12,248 | 12,248 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges